Danicopan

A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNH

Danicopan Early Access Program

Assess Long-Term Safety of Danicopan Add-on Therapy in Participants With Paroxysmal Nocturnal Hemoglobinuria: Analysis of IPIG-Registry Data

Long-term Safety of Danicopan: IPIG Registry-based Cohort Study

Study of Danicopan as Add-on Treatment to Ravulizumab or Eculizumab in Pediatric Participants With PNH Who Have Clinically Significant Extravascular Hemolysis

A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Danicopan as Add-on Therapy to a C5 Inhibitor in Paroxysmal Nocturnal Hemoglobinuria (PNH) Participants Who Have Clinically Evident Extravascular Hemolysis (EVH)(ALPHA)

Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria With Inadequate Response to Eculizumab

A Proof of Concept Study for a 12 Month Treatment in Patients With C3G or IC-MPGN Treated With ACH-0144471

ACTIV-5 / Big Effect Trial (BET-C) for the Treatment of COVID-19

A Study of the Effects of Food and Age on Danicopan

A Proof-of-Concept Study of Danicopan for 6 Months of Treatment in Participants With C3 Glomerulopathy (C3G)

Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

A Study of the Drug Interactions Between Danicopan and Cyclosporine, Tacrolimus, Antacids, and Omeprazole in Healthy Adults

A Proof-of-Mechanism Study to Determine the Effect of Danicopan on C3 Levels in Participants With C3G or IC-MPGN

A Study of the Cardiac Effects of Danicopan in Healthy Adults

Study of Danicopan in Participants With Hepatic Impairment

A Drug Interaction Study Between Danicopan and Midazolam, Fexofenadine, and Mycophenolate Mofetil in Healthy Participants

Study of Danicopan in Participants With Normal Kidney Function and Participants With Kidney Dysfunction

Study of Multiple Doses of Danicopan in Healthy Participants